Dr. Isaac Bright joined Imagion Biosystems as Chief Executive Officer in June 2023. Before entering Imagion, Dr. Bright served as Co-Founder, CEO, and Chairman of RubrYc Therapeutics, Inc. before its trade sale to iBio, Inc. (NYSEA: IBIO) in September 2022. Prior to launching RubrYc, Dr. Bright was Chief Business Officer for molecular diagnostics innovator HealthTell, […]
Dr. Grint was most recently CEO and a member of the board of directors of AmpliPhi Biosciences which recently merged with C3J Therapeutics to form Armata Pharmaceuticals. Dr. Grint has more than two decades of experience in biologics and small molecule research and development, including the successful approval and commercialization of products in the infectious […]
Prof. Andrew Scott is Laboratory Head at the Olivia Newton-John Cancer Research Institute; Director, Department of Molecular Imaging and Therapy, Austin Health; and Professor, University of Melbourne, La Trobe University, and Monash University. His clinical and research interests are focused on developing innovative strategies for targeted therapy of cancer with monoclonal antibodies, and in molecular […]
Dr. Ivkov’s research focuses on the development and characterization of magnetic nanoparticles and AMF-devices for cancer therapy. Upon his arrival to the Department of Radiation Oncology and Molecular Radiation Sciences at The Johns Hopkins University School of Medicine in early 2008, Dr. Ivkov began a broad research program with the aim to develop clinical applications […]
Prof Lisa Horvath is the Director, Department of Medical Oncology, and inaugural Director of Research at the Chris O’Brien Lifehouse. She is also the Professor of Medical Oncology (Genitourinary cancer) at the University of Sydney and Head of Clinical Prostate Cancer Research at the Garvan Institute for Medical Research. She has an active clinical practice […]
John Hazle, Ph.D. is Professor and Chair of the Department of Imaging Physics at one of the world’s largest cancer research and treatment centers. In his role as the Chairman of the Scientific Advisory Board, John represents the interests and professional requirements of an uncompromising customer who buys and uses advanced diagnostic instrumentation on a […]
Jovanka is an Australian legal practitioner with expertise in intellectual property law, corporate law, and corporate governance. She serves Australian scientific development organizations in an expert capacity on matters relating to corporate law, business operations, intellectual property development, and regulatory compliance.
Mark has over 30 years of experience in the medical diagnostics and life science industry. Much of this time has been specific to international business development, strategic planning and introduction of new technology. Through Diagnostic Technology, a company he founded, he has been responsible for the development and introduction of a number of innovative technology […]
Geoff recently spent two years as CFO and Company Secretary of Victory Offices Limited, a leading provider of flexible workspace solutions, leading the company through an IPO on the Australian Stock Exchange. Prior to this, Geoff spent 8 years as CFO and Company Secretary with Lifestyle Communities Limited, a fast growing ASX listed provider of […]
Marie Zhang, PhD, MBA, is a problem-solver and an effective scientific leader specializing in pharmaceutical and research reagent product development. Now overseeing the R&D team at Imagion Biosystems, she is presently directing the development of MagSense technology test reagents. Dr. Zhang brings more than 20 years of diverse industry experience, including significant management and scientific […]
Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance
